United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2024, from 2 sources
From Vittoria Biotherapeutics, Inc.'s own website and the SEC filings it signed: 1 founder, 7 on the team.
On the board, as filediLeon MoulderNicholas Siciliano
AdvisersJim Weissman
Missing a round, or an investor who was in one? Tell us.
Vittoria Biotherapeutics, Inc.'s investors include Valley Forge Investment Corporation, Agent Capital, NYBC Ventures, Global BioAccess Fund and Tellus BioVentures, and 2 more on record. Valley Forge Investment Corporation led its latest round.
Vittoria Biotherapeutics, Inc. has raised $25M across 1 round since 2024.
Vittoria Biotherapeutics, Inc.'s most recent round was an Undisclosed round of $25M in Nov 2024, led by Valley Forge Investment Corporation.
Its most recent round, $25M in Nov 2024, is also its largest on record.
Vittoria Biotherapeutics, Inc.'s first round on record, in Nov 2024, was backed by Valley Forge Investment Corporation, Agent Capital and NYBC Ventures and 4 others.
Vittoria Biotherapeutics, Inc.'s latest named round is an Undisclosed round, in Nov 2024.
Vittoria Biotherapeutics, Inc. is based in the United States.
Valley Forge Investment Corporation led the Undisclosed round in 2024.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
